Insider Trading History of Jackson Andrew C.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Jackson Andrew C. since 2019. This trader's CIK number is 1636738. At the time of last reporting, Jackson Andrew C. was the Chief Financial Officer of Calidi Biotherapeutics, Inc.. (stock ticker symbol CLDI). Also see all insider trading activities at Calidi Biotherapeutics, Inc..

Note that in the past Jackson Andrew C. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Catheter Precision, Inc. (RMED) by Jackson Andrew C.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 RMED 0 $0 2,684 $7,032 0 $0
2020 RMED 20,000 $8,150 0 $0 0 $0
2019 RMED 0 $0 5,134 $15,792 0 $0

Yearly summary of insider trading at Calidi Biotherapeutics, Inc. (CLDI) by Jackson Andrew C.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 CLDI 2,500 $5,000 0 $0 0 $0


Insider trading activities at 2 companies by Jackson Andrew C.:

1. Catheter Precision, Inc. (RMED)

2. Calidi Biotherapeutics, Inc. (CLDI)

Table 1. Insider trading of Catheter Precision, Inc. (RMED) by Jackson Andrew C.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-11-22 RMED Sale 2,684 2.62 7,032
2020-08-03 RMED Buy 10,000 .35 3,500
2020-05-22 RMED Buy 10,000 .47 4,650
2019-06-13 RMED Sale 5,134 3.08 15,792

Table 2. Insider trading of Calidi Biotherapeutics, Inc. (CLDI) by Jackson Andrew C.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-08-21 CLDI Buy 2,500 2.00 5,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Jackson Andrew C. (Chief Financial Officer of Calidi Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.